Abstract

Objective: This study aimed to determine the correlation between periodontal status and BMI by evaluating salivary biomarkers - Resistin, visfatin, and TNF-α. 
 Methods: Among 580 screened subjects, 86 subjects (30 male and 56 female) aged 30-60 years recruited and grouped into four groups, Group 1 – non-obese with healthy periodontium, group 2 – non-obese with periodontitis, group 3 - obese with healthy periodontium, and group 4 - obese with periodontitis, according to their clinical periodontal parameters and BMI. (ELISA) was used to measure the salivary concentration of Resistin, Visfatin, and TNF-α. (SPSS, v.20.0) applied for statistical analysis, Shapiro-Wilk used to test the Normality of distribution. One-way ANOVA and Mann-Whitney U test were used to analyze the outcome data.
 Results: Significant differences in the clinical variables (PI, BI, PPD, and CAL) between test and control groups, with and with no periodontitis (P<0.05). However, no significant differences (P>0.05) between the level of Resistin were detected in the four groups tested. TNF-α was and periodontitis obese groups (P-value< 0.05). No significant correlations were found between clinical periodontal parameters and BMI and the three biomarkers' levels in the four groups tested in this study.
 Conclusions: The study failed to detect significant positive correlations between the salivary biomarkers' levels and clinical periodontal and obesity parameters.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.